Feel Free
to Learn

News & Events

The safety and efficacy studies performed on animals, 6 healthy volunteers and a group of 28 constipated patients show that the vibrating capsule is safe and improves the average number of spontaneous bowel movements per week from 2.19 to 3.79 (p<0.001), making it a new promising therapeutic option for the … Read More

Vibrating Capsule for the Treatment of Chronic Idiopathic Constipation (CIC) and Constipation Predominant Irritable Bowel Syndrome (C-IBS) – Safety and Efficacy,” has been selected for inclusion in the press program for this year’s Digestive Disease Week® (DDW), to be held May 3-6, 2014, in Chicago … Read More

Vibrant successfully completed its phase I and II clinical trial. The phase I study was conducted on 6 healthy volunteers and the phase II on 28 chronically constipated patients. Both trials demonstrated safety of the vibrating capsule. The phase II study indicated efficacy of the capsule. For more information, please … Read More

Vibrant will report results of a pilot trial at the 20th United European Gastroenterology Week, to be held in Amsterdam, The Netherlands, October 20-24, 2012. Poster with the results will be presented on October 23, between 9:00–17:00 at the poster session “Other Lower GI Disorders II”, Hall 1 (poster number: … Read More

PetachTikva, Israel, June 25, 2012. Vibrant Ltd., a medical device company, today announced a chemical-free capsule for patients suffering from constipation. The capsules, mechanically operated, aid in treating constipated patients without side effects. The mechanical capsule meets the highest safety standards, using biocompatible materials Constipation relief is achieved by … Read More

Lior Ben-Tsur, Vibrant’s CEO, will present Vibrant’s technology at ILSI-Biomed 2012 Conference, to be held at the David InterContinental Hotel, Tel Aviv, Israel, May 21-23, 2012. Ben-Tsur’s presentation will be held on May 22, 2012 at 1:10 pm, at the medical device session. Read More